Nuclear hormone receptors comprise a superfamily of liganddependent transcription factors that regulate gene expression through interaction with specific hormone response elements (HREs) 1 in target genes. The superfamily can be subdivided into: 1) classical steroid hormone receptors that typically interact with palindromic hexameric HREs as homodimers, 2) nonsteroidal or class II nuclear receptors for ligands such as thyroid hormone, retinoic acid, vitamin D, and fatty acids, that function primarily as heterodimers with RXR (retinoid X receptor) bound to direct repeat HREs, and 3) orphan receptors without known ligands that interact with HREs in various dimer and monomer configurations. The nuclear receptors are related through a common domain structure including conserved C-terminal ligand binding (LBD) and centrally located DNA binding domains (DBD), and a variable N-terminal domain that is required in many nuclear receptors for maximal transcription activity (Refs. 1 and 2, reviews). The DBD consists of a highly conserved core with two asymmetric zinc fingers and an ϳ30 amino acid segment, termed the C-terminal extension (CTE) (Fig. 1A) . Within the core DBD, ␣-helix 1 extends between the two zinc fingers and makes base specific contacts in the major groove of the HRE DNA. The second ␣-helix (helix 2) does not contact DNA but is important for the overall folding of the core DBD (3) (4) (5) . The CTE is not conserved and adopts different structural motifs dependent on the class of nuclear receptor (6, 7) . Nonetheless, the CTE of different receptors does appear to share a functional role to stabilize the receptor-DNA complex by extending the protein-DNA interface beyond that of base-specific contacts made by the core DBD. The CTE of class II receptors (TR and VDR) forms an ␣-helix (helix 3) that projects across the minor groove between HRE half-sites, making extensive contacts along the phosphate backbone required for high affinity DNA binding and correct spacing with the RXR heterodimer (8, 9) . The CTE of orphan receptors forms an extended loop conformation that makes base-specific contacts in the minor groove immediately 5Ј of the HRE. A short peptide motif termed a "GRIP-box" (RXGRZP where X is any amino acid and Z is a hydrophobic residue) mediates interaction of orphan receptor CTEs with the minor groove (10, 11) . The CTE is also required for monomeric orphan receptor recognition of extended HRE half-sites through interaction with specific tri-nucleotide sequences in the minor groove just 5Ј of the HRE (12, 13) .
Although no structural information is available as yet, biochemical evidence indicates the CTE of steroid receptors also has a role in mediating high affinity DNA binding, by interacting with high mobility group proteins, HMGB-1 and HMGB-2, that function to facilitate receptor binding to cognate target DNA sites (14) . HMGB-1 and closely related HMGB-2 (formerly known as HMG-1 and -2) are members of a family of proteins that bind to duplex B-DNA with moderate affinity and little sequence specificity, but recognize and bind with high affinity to various distorted DNA structures. The nomenclature of HMGB-1 and -2 was adopted in 2001 to designate the canonical HMG "Box" DNA binding domains of these proteins (15) . In addition to recognizing distorted DNA targets, the HMG Box also binds in the minor groove and induces sharp bends and distortions in linear duplex DNA. Thus by increasing the flex-ibility of DNA, HMGB-1/-2 are thought to have a general architectural role in the assembly of nucleoprotein complexes involved in regulation of transcription (see reviews in Refs. 16 -18) . Although HMGB-1/-2 enhance DNA binding and transcription activity of all steroid hormone receptors analyzed, including receptors for progesterone (PR), androgen (AR), glucocorticoids (GR), mineralocorticoids (MR), and estrogen (ER-␣), they have no influence on class II nuclear receptors (19 -21) . This selective effect on the steroid class of nuclear receptors is dependent on the CTE and correlates with a direct protein interaction between HMGB-1/-2 and the CTE that does not occur with class II receptors (14, 20) . HMGB-1/-2 also interacts with select groups of apparently unrelated sequence-specific transcription factors including p53 (22) , p73 (23) , Hox proteins (24), Oct proteins (25) , Rel family members (26) , and EBV transcription factors Rta and Zebra (27, 28) , to enhance their binding to cognate DNA sequences and transcription activity.
The biological actions of estrogen are mediated by two estrogen receptor subtypes, ER␣ and ER␤, expressed from separate genes (29) . The precise physiological role of the two ER subtypes is not yet well defined. Genetic ablation experiments in mice suggest the effects of estrogen on development and differentiation of female reproductive target tissues are mediated predominantly by ER␣, whereas ER␤ is more important in development of the ovary and perhaps other non-reproductive tissues (Ref. 30 for review). ER␣ is a more potent transcriptional activator than ER␤ in cell culture based assays (31) and in cell-free transcription assays with chromatin templates containing multiple EREs (32) . Interestingly, ER␣ and ER␤ exhibit similar ligand-dependent transcriptional activities with naked DNA templates in vitro, indicating a role for chromatin in distinguishing the intrinsic activities of the two ERs (32) . Swapping experiments with the N-terminal regions of ER␣ and ER␤ showed that this differential transcription potency both in vivo and in vitro is largely attributable to the N-terminal domain (31, 32) . In tissues that express both ERs, a role for ER␤ as an attenuator of ER␣ activity has been suggested (33-34).
Despite the fact that the core DBDs of ER␣ and ER␤ are nearly identical with a 96% amino acid identity, ER␣ has been reported to have a higher affinity for estrogen response elements (EREs) than ER␤ (35) (36) (37) , and only ER␣ is capable of inducing a directed bend in ERE target DNA (38) . The differential ability to induce a directed bend in DNA has been attributed to the CTEs of ER␣ and ER␤ (38) . The mechanism for the higher DNA affinity of ER␣ is not known, but is likely due to differences in the CTE or other regions outside the highly conserved core DBDs.
The only member of the steroid class of nuclear receptors that has not been analyzed for interaction with HMGB-1/-2 is ER␤. Therefore, in the present study, we sought to further examine the role of the steroid receptor CTE in DNA binding and response to HMGB-1/-2 by performing a comparative analysis of ER␣ and ER␤. HMGB-1/-2 stimulated DNA binding and transcription activity of both ER␣ and ER␤ and the CTE was required for physical interaction with and functional responsiveness to HMGB-1/-2. The CTE was also found to be responsible for the different intrinsic DNA binding affinities of ER␣ and ER␤ independent of HMGB-1/-2. Unexpectedly, the CTE was also required for ER␣ and ER␤ interaction with half-site EREs.
EXPERIMENTAL PROCEDURES
Expression and Purification of GST Fusion Proteins-The expression vectors for GST-HMGB-1 and the ER␣ DBD (amino acids 198 -288) have been described previously (14) . All other DNA-binding domain (DBD) vectors were constructed similarly by subcloning into pGEX2T (Amersham Biosciences), with an in-frame glutathione S-transferase (GST) for expression as a GST fusion protein. Chimeric DBDs were subcloned using "splicing by PCR overlap extension" as previously described (14) , and also inserted into pGEX2T (Amersham Biosciences).
DBD-GST fusion proteins were expressed in Bl21 bacterial cells and purified by a three-step procedure including affinity chromatography on glutathione-Sepharose resins and thrombin cleavage to remove the GST moiety, DNA cellulose, and FPLC gel filtration by Superdex-30 chromatography. The final product was concentrated by an Amicon stirred cell concentrator (39) . Purified DBD concentrations were deter- mined by comparison to known concentrations of lysozyme on silver stain SDS gel electrophoresis. Relative DNA binding affinity differences were verified using independently purified DBDs, and protein concentrations were determined independently by Lowry assay and UV spectrophotometric quantitation methods using extinction coefficients of 13,260 for both ER␣ and ER␤ DBDs.
Production and Purification of Baculovirus-expressed Recombinant Proteins-Full-length human PR-A and HMGB-2 with N-terminal 6ϫ histidine tags, and human ER␣ and ER␤ with N-terminal FLAG sequences (DYCDDDDK) were expressed from baculovirus vectors in Sf9 insect cells as described (19, 40) . For ER␣ and ER␤, estradiol 17␤ (200 nM) was added to Sf9 cell cultures to activate receptors during expression in vivo. His-tagged proteins were purified by nickel affinity resins as previously described for PR except that HMGB-2 was dialyzed against 20 mM Tris, pH 8.0, 100 mM NaCl, 10% glycerol, and 1 mM DTT to exchange the ␤-mercaptoethanol for DTT and prevent oxidation (14, 16 -19) . FLAG-tagged ER␣ and ER␤ were purified as described (40) except that the receptors were eluted from anti-FLAG-affinity resins in a buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 20% glycerol, 50 M ZnCl 2 , 0.2 mM EDTA, 2 mM DTT, 0.1% Nonidet P-40, 0.1 mg/ml FLAG peptide, and 0.5 mg/ml insulin. The eluates were then dialyzed against elution buffer with higher Nonidet P-40 (0.2%) and lacking the FLAG peptide. Purified proteins were analyzed by silver stain or Coomassie Blue-stained SDS gel electrophoresis and judged to be at Ն90% pure.
Electrophoretic Mobility Shift Assays (EMSAs)-EMSAs for fulllength ER␣ and ER␤ were performed as described previously (14, 19) in a DNA binding reaction containing 10 mM HEPES, pH 7.8, 100 mM KCl, 20% glycerol, 4 mM MgCl 2 , 1 mM DTT 0.1 g poly(dI-dC), 5 g of ovalbumin, and 0.6 nM 32 P-labeled duplex DNA fragments formed from the appropriate oligonucleotides. Binding reactions were carried out for 30 min at 4°C and samples were then electrophoresed at 4°C on non-denaturing 5% polyacrylamide gels (40:1 acrylamide/bisacrylamide ratio) containing 2.5% glycerol impregnated in the gels, and 0.25ϫ TBE (0.02 M Tris, pH 8.0, 0.02 M boric acid, 0.5 mM EDTA) as running buffer. Isolated DBDs used a binding reaction containing 10 mM Tris, pH 8.0, 50 mM KCl, 6% glycerol, 1 mM DTT, 100 ng of poly(dI-dC), and 0.1% Nonidet P-40 or Igepal CA630 (Sigma), and samples were electrophoresed on 8% polyacrylamide gels. Gels were dried, autoradiographedm and free [ 32 P]DNA and [ 32 P]DNA-protein complexes were quantitated by direct scanning of gels for radioactivity by a series 400 Molecular Dynamics PhosphorImager. Data were expressed graphically as the normalized fraction of DNA bound versus DBD concentration. For EMSAs that exhibited two mobility ER-complexes, bound DNA was taken as the sum of both complexes. The fraction bound DNA was calculated as 1-(free DNA/(bound DNAϩfree DNA)). The data were normalized by setting the fraction of DNA bound at saturation to 1.0 and all other values were a fraction of 1.0 (41). Saturation typically occurred at fraction bound values of 0.7 to greater than 0.9.
All DNA binding curves were best fit to the following equation:
, where y is the normalized fraction DNA bound, x is the total DBD concentration, and n is the Hill cooperativity coefficient. The Hill cooperativity coefficient varied from n ϭ 1 to 2, and the curves shown are the best fit of the data by Kaleidagraph using an R value ϭ 1. The apparent dissociation constant (K dapp ) was determined as the DBD concentration at which y ϭ 0.5 from the average curve of at least three independent experiments. Double-stranded DNA fragments were end-labeled by Klenow fill-in of 5Ј-overhanging ends with [␣-
32 P]dATP and [␣-32 P]dCTP: EREpal 5Ј-gatcGATTTGTCAAGGTCACTGTGACCTTGACACAGT-3Ј; TCA-EREhalf 5Ј-gatcGATTTGTCAAGGTCAGATGGCGGGCACAGTCTAG-3Ј; and TAG-EREhalf 5Ј-gatcGATTTGTAGAGGTCAGATGGCGGG-CACAGTCTAG-3Ј.
Mammalian Cell Transfection-CV-1 cells were transfected by an adenovirus-mediated method as previously described (14, 19) , and at 24-h post-transfection, cells were treated with or without estradiol 17␤ (10 nM) for 24 h at 37°C. The total amount of plasmid DNA in each transfection was equalized with empty vector (pBlueScript) such that each well received equimolar amounts of plasmid DNA. A pRSV-␤Gal plasmid was included in each transfection as an internal control for well-to-well variation in transfection efficiency. Cell lysates were assayed for luciferase and ␤-galactosidase activities with a Monolight 2010 luminometer as described previously (14, 19) . Luciferase values were corrected for variations in transfection efficiency by calculating luciferase/␤-galactosidase ratios (LUC/␤GAL).
GST Pull-down Assays-Bacterial cell lysates expressing GST or GST-HMGB-1 were incubated in suspension with 25 l of glutathione Sepharose beads in 500 l lysis buffer (20 mM Tris-HCl, pH 7.5, 1 M NaCl, 5 mM DTT, 1 mM EDTA, 50 M ZnCl 2 , 10% glycerol, and protease inhibitors) for 1h at 4°C. Beads were washed three times in lysis buffer and followed by washing in binding buffer (10 mM Tris, pH 7.8, 50 mM NaCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, and 10% glycerol). Receptor DBDs (1 g), were added and incubated in suspension for 1 h (250 l) at 4°C. Beads were then pelleted, washed in binding buffer, and protein was eluted in SDS sample buffer and analyzed by Western immunoblot with a rabbit polyclonal antisera raised against peptide sequences in the ER DBDs (42) .
RESULTS AND DISCUSSION
HMGB Enhances the DNA Binding Affinity and Transcriptional Activity of ER␤-Although ER␣ and ER␤ can activate many of the same target genes in response to estrogen, ER␤ has been reported to exhibit a 3-4-fold lower affinity for EREs and as much as a 10-fold weaker transcriptional activity than ER␣ (31) (32) (33) (34) (35) (36) (37) . Therefore, we sought to determine whether a difference in interaction with HMGB-1/-2 contributes to these distinct activities of ER␣ and ER␤. We previously found that HMGB-1 and -2 are functionally interchangeable with respect to stimulating the DNA binding affinity of steroid receptors in vitro and enhancing transcriptional activity in mammalian cells (19) . Therefore, HMGB-1 and -2 were used interchangeably and are collectively referred to as HMGB in the remainder of this article. Receptor DNA binding was analyzed by electrophoretic gel mobility shift assay (EMSA) by varying the concentration of receptors in the presence of a constant amount of 32 P-labeled DNA probe. The DNA duplex fragment contains a consensus palindromic ERE based on the well characterized ERE in the vitellogenin gene (36) that is recognized by human and other species of ER. As shown in Fig. 2 A and B , purified full-length ER␣ and ER␤ bound to EREpal in a dose-dependent, saturable manner. Based on apparent dissociation constants (K dapp ) estimated from the ER concentration at halfmaximal DNA binding, ER␣ bound to the EREpal with a 4-fold higher affinity than ER␤ (Fig. 2B ). This affinity difference is consistent with previous reports that ER␣ has a higher affinity for EREpal than ER␤ (35) (36) (37) . For both ERs, addition of HMGB significantly left-shifted the DNA binding curves (Fig. 2B) , indicating an increase in binding affinity for EREpal. In the absence of HMGB, ER␣ and ER␤ produced two protein-DNA complexes and both contained ER␣ or ER␤, respectively, as demonstrated by supershifts with ER␣-or ER␤-specific antibodies ( Fig. 2A) . The exact nature of the two mobility ER complexes is not known. Both complexes were obtained in the absence of HMGB, indicating that they do not represent ERcomplexes containing and lacking HMGB. Because it is well accepted that ER preferentially binds to EREpal as a dimer, suggests the faster mobility complex contains an ER dimer, whereas the slower mobility complex contains a higher order ER oligomer ( Fig. 2A) . At low concentrations of ER (␣ and ␤), addition of HMGB stimulated the formation of both mobility complexes, but at high receptor concentrations, HMGB predominantly stimulated the slower mobility complex concomitant with a decrease of the faster mobility complex (Fig. 2A) . Multiple mobility ER complexes have been reported previously, but the relevance of the different complexes to ER function is not known (36) . HMGB was not retained as a stable component of the stimulated complexes, as they have the same mobility as the unstimulated complexes ( Fig. 2A) and are not supershifted by HMGB antibodies (data not shown). Ternary HMGB complexes by EMSAs have not typically been detected with steroid receptors or other transcription factors, suggesting HMGB acts as a DNA chaperone in a transient manner to facilitate binding of transcription factors to their cognate target DNA (18 -27) .
To determine the influence of HMGB on the transcription activity of ER␤, cell-based transcription assays were performed by transfection of ER negative CV-1 or COS-1 cells with ER expression plasmids, a luciferase reporter gene consisting of five copies of the vitellogenin ERE inserted in place of GRE/ PRE sequences of MMTV (MMTV-ERE) as previously described (43) , and varying amounts of expression plasmid for HMGB-1. As shown in Fig. 2C , estrogen induction of MMTV-ERE-luc was mediated by ER␣ and ER␤ in a similar receptor plasmid dose-dependent manner, except that ER␣ mediated a higher level of luciferase expression than ER␤ at all doses. Thus, under these conditions, we confirm the higher transcriptional potency of ER␣ (31, 32) . Ectopic expression of HMGB-1 stimulated estrogen-induced ER␣-mediated activation of the ERE-luc reporter gene expression in a dose-dependent manner by ϳ3-fold at the highest amount of HMGB-1. Under the same conditions, HMGB-1 enhanced ER␤ mediated transcription by approximately the same amount (Fig. 2D) . These are the first data to show HMGB enhancement of ER␤ DNA binding and transcription activity and thus extend and complete previous results indicating HMGB is a common co-regulatory protein for all steroid receptors (7, 14, 19, 20, 21) . These results also suggest that the higher DNA binding and transcription activity of ER␣ over ER␤ is not due to a lack of ER␤ responsiveness to the HMGB. Differences in DNA binding affinity and transcriptional activity of ER␣ and ER␤ were largely maintained under HMGB stimulated conditions. 
The CTE of ER␣ and ER␤ Is Required for Physical and
Functional Interaction with HMGB-1/-2-In our previous studies of PR, the CTE was required not only for protein interaction with HMGB and for HMGB enhancement of DNA binding in vitro, but also for HMGB stimulation of transcriptional activity in mammalian cells. This was shown by use of receptor chimeras consisting of swaps between the CTEs of PR and TR. In cell-based transcription assays, enhancement of PR transcription activity by ectopic expression of HMGB was largely dependent on the PR CTE and substantially reduced by the presence of the TR CTE (14) .
To determine whether the CTE of ER␣ and ER␤ has a similar role as it does in PR, we analyzed the effect of HMGB on DNA binding by ER DBDs containing or lacking the CTE (Fig.  3A) . Full-length ER DBDs contained the zinc finger core plus C-terminal sequence of length comparable to that of the PR CTE (Figs. 1 and 3A) . Full-length ER␣ and ER␤ DBDs exhibited dose-dependent, saturable binding to EREpal. Addition of HMGB increased the apparent binding affinity of both ER DBDs, enabling the formation of DNA complexes at lower concentrations than observed in the absence of HMGB (Fig. 3, B  and C) . The K dapp for ER␣ DBD binding to EREpal was 0.54 ϫ 10 Ϫ9 M, while ER␤ DBD exhibited an ϳ3-fold lower affinity with a K dapp of 1.53 ϫ 10 Ϫ9 M (Table I) . Addition of HMGB increased the apparent DNA binding affinity of ER␣ DBD by 4.2-fold (K dapp of ER␣ DBD to 0.13 ϫ 10 Ϫ9 M) and ER␤ DBD by 2.5-fold (0.61 ϫ 10 Ϫ9 M) ( Table I) . As with full-length ER, multiple mobility complexes were detected with ER DBDs, including predominantly ER DBD dimers and small amounts of monomer and higher order complexes. HMGB enhanced ER␣ DBD-DNA complexes primarily as dimers and high order oligomers (Fig. 3B) . Similar complexes were also observed with the ER␤ DBD; however, the higher-order complexes were less abundant than those observed with ER␣ (Fig. 3B) . These results indicate that the DBD of both ER subtypes contain elements sufficient for HMGB stimulation of receptor DNA binding, and that the affinity difference of ER␣ and ER␤ for EREpal is largely due to intrinsic differences in their respective DBDs. Truncated DBD constructs, termed ER␣t and ER␤t, contained the core DBD through the conserved Gly-Met, but lacked most of the CTE (Fig. 3A) . The truncated ER DBDs bound to EREpal primarily as dimers with no evidence of higher order complexes (Fig. 3D) . In contrast to DBDs with the CTE, addition of HMGB had no effect on binding of either truncated ER␣ or ER␤ DBDs to an EREpal (Fig. 3D) . Thus, the CTEs of both ER␣ and ER␤ are required for functional response to HMGB-2 in terms of enhancement of receptor binding to specific DNA sequences.
To determine whether the ER CTE is also required for direct protein interaction with HMGB, we performed GST pull-down assays with full-length (core zinc finger plus CTE) and truncated ER DBDs (lacking the CTE). As shown in Fig. 3E , ER␣ and ER␤ DBDs bound directly to GST-HMGB-1, but had minimal interaction with free GST. However, the truncated ER DBDs, ER␣t and ER␤t, did not interact with HMGB-1 at all (Fig. 3E) . These data taken together indicate that the CTE of ER␣ and ER␤ is required for both physical and functional interaction with HMGB-1/-2.
The mechanism by which HMGB interacts specifically with the CTE of steroid receptors, and how this interaction enhances DNA binding and transcription, is not known. Facilitated binding of transcription factors to their cognate DNA sites by HMGB is thought to be due to the DNA binding and DNA bending properties of HMGB, whereby HMGB helps to induce or stabilize a DNA conformation that forms the most favorable binding site for the transcription factor. However, because HMGB has minimal specificity for binding DNA sequences, recruitment to specific promoters likely requires targeting through protein-protein interaction with a sequence-specific DNA-binding protein. In addition to simply recruiting HMGB to specific promoters for the purpose of manipulating DNA structure, our data suggest that protein interaction with HMGB may also have a role in directly influencing the DNA binding activity of steroid receptors. The CTEs of class II and orphan nuclear receptors are structured and directly participate in DNA binding. In contrast, the CTEs of steroid receptors appear to be unstructured and constitute a binding site for HMG, suggesting that HMGB interaction may induce or stabilize the structure of the CTE necessary for it to contact DNA and extend the protein-DNA interface beyond that formed by the core DBD. Although the CTEs of steroid receptors have little amino acid sequence similarity or identity (Fig. 1B) , they may adopt a common structural fold or binding surface recognized by HMGB. The CTE Is Responsible for the Higher DNA Binding Affinity of ER␣-Because the ER␣ and ER␤ core DBDs share greater than 95% amino acid identity, we sought to determine whether the non-conserved CTE region was responsible for the DNA binding affinity difference between the ER␣ and ER␤. We created chimeric DBDs in which the CTEs were swapped between the ER subtypes (Fig. 4A) . The ER␤/␣ chimera contained the ER␤ core DBD fused to the ER␣ CTE; conversely, the ER␣/␤ chimera consisted of the core DBD of ER␣ fused to the CTE of ER␤ (Fig. 4A) . We compared DNA binding of these chimeric DBDs with that of the ER␣ and ER␤ DBDs in quantitative EMSA (Fig. 4, B and C) . The binding curve for the ER␤/␣ DBD chimera was nearly superimposable with that of ER␣ DBD (Fig. 4C) , exhibiting a 6-fold higher apparent DNA binding affinity than that of ER␤ DBD (Table I , K dapp ϭ 0.26 ϫ 10 Ϫ9 M for ER␤/␣ DBD and 1.53 ϫ 10 Ϫ9 M for the ER␤ DBD). Conversely, the ER␣/␤ chimera exhibited ϳ3 fold lower affinity than that of ER␣ DBD (Table I , K dapp ϭ 1.9 ϫ 10 Ϫ9 M for ER␣/␤ and K dapp ϭ 0.54 ϫ 10 Ϫ9 M for ER␣ DBD). Thus domainswapping resulted in a substantial switch in the DNA binding affinities of the two ER subtypes, indicating the CTE is largely responsible for the affinity differences between ER␣ and ER␤. How the CTE of ER␣ contributes to a higher DNA binding affinity than ER␤ is not known. Schultz et al. (38) showed by similar domain-swapping experiments that the CTE accounted for the differential ability of ER␣ and ER␤ to bend DNA. Deformation of DNA structure could lead to a more stable protein-DNA complex through altering protein-DNA contacts or lowering the energetics of binding.
A previous study by one of the authors (32) showed that ER␣ and ER␤ bind to tandemly arrayed EREs assembled into chromatin in vitro with similar apparent affinities and can initiate chromatin remodeling on those templates with similar efficiencies. Under such conditions (i.e. with multiple EREs), the intrinsic differences in the potencies of the ER␣ and ER␤ activation domains are maximized. Likewise, the intrinsic differences in their DNA binding activities may be minimized. In vivo, where the estrogen-responsive genes studied to date typically have a single imperfect ERE with or without flanking ERE half-sites, the 3-4-fold differences in the DNA binding affinities of ER␣ and ER␤ that we have observed in our assays with single EREs may play a significant role in ER subtype-specific gene regulation.
ER␣ and ER␤ Exhibit a Similar Ability to Interact with ERE Half-sites Dependent on the CTE-A previous study from
Vanacker et al. (44) reported that ER␣, but not ER␤, was capable of binding ERE half-site elements in vitro and mediating functional responses from ERE half-sites in cells. Furthermore, ERE half-site binding by ER␣ required a specific TCA trinucleotide sequence immediately flanking the 5Ј-end of the ERE half-site, reminiscent of how orphan receptor monomers interact stably with extended half-site HREs through the GRIP box of the CTE. The CTE of ER␣ (Fig. 1A) , but not ER␤, contains a GRIP box-like sequence similar to the orphan receptors SF-1 (steroidogenic factor 1) and ERR (estrogen-related receptor) (11, 45) that require CA dinucleotides at the 5Ј-end of HRE half-sites. This suggested to us that the ER␣ CTE might be responsible for the reported ability of ER␣, but not ER␤, to bind to ERE half-site elements (44) . However, when we compared binding of purified full-length ER␣ and ER␤ to ERE half-site probes containing TCA or the mutated TAG 5Ј-flanking trinucleotide sequence (Fig. 5A) , both ER subtypes bound equally well to either probe (Fig. 5, B and C) . Binding of ER␣ and ER␤ to the ERE half-sites was also stimulated in a similar manner by the addition of HMGB-2 (Fig. 5, B and C) . As with binding of full-length ER␣ and ER␤ to EREpal, two mobility complexes were obtained with ERE half-site probes, although the slower mobility complex with ER␤ is much weaker than that formed by ER␣ (Fig. 5, B and C) . The mobilities of the two complexes on ERE half-sites are similar to those obtained with EREpal ( Fig. 2) , suggesting they also contain an ER dimer (faster complex) and higher order ER oligomer (slower complex). Because full-length ER dimerizes in solution through the ligand binding domain, ER dimers can interact with ERE halfsites through one of the DBD subunits and would be expected to have the same mobility by EMSA as an ER dimer bound to EREpal.
Because the dimerization domain in the DBD is dependent on DNA binding, the ER DBDs, as expected, bound to the ERE half-sites as monomers instead of dimmers (Fig. 6, A and B) . The ER␣ and ER␤ DBDs also bound equally to both TCA-and TAG-ERE half-site probes (Fig. 6, A and B) , and addition of HMGB increased the affinity of both ER subtype DBDs for the ERE half-sites by a similar ϳ5-fold (Table I) . Similar to results with EREpal, the ER␣ DBD has ϳ3-fold higher affinity than the ER␤ DBD for ERE half-sites (Table I ). Thus our results do not show a differential ability of ER␣ and ER␤ to recognize ERE half-sites and further suggests that the GRIP box-like sequence of ER␣ CTE does not confer TCA specificity for sequences flanking the ERE-half as it does with orphan receptors. Why our results differ from that of Vanacker et al. (44) is not known, but could be due to different experimental methods and conditions. They used vitro synthesized ER␣ and ER␤ from a rabbit reticulocyte lysate coupled transcription/translation assay, whereas our results were obtained with highly purified, baculovirus-expressed ERs. Receptors may be modified differently in the two systems or may be influenced by other interacting factors in the rabbit reticulocyte lysate system. Additionally, Vanacker et al. (44) analyzed the requirements of flanking sequences indirectly by competition with unlabeled DNA duplexes for binding of ER to the radiolabeled TCA-ERE half-site probe. We analyzed direct binding of ERs to both [ 32 P]TCA and TAG ERE half-sites, which does not have the inherent limitation of estimating relative binding affinities by competition.
Despite the fact that the CTE was not required for ER binding to a full EREpal probe (Fig. 3D) , we observed that it was required for binding to ERE half-sites independent of 5Ј-flanking sequences. Neither of the ER DBDs lacking the CTE interacted with either extended ERE half-site probe, even at the highest concentrations of receptors ϳ2 ϫ 10 Ϫ6 M (Fig.  6C) . As anticipated, addition of HMGB-2 did not promote interaction of these truncated ER DBDs with ERE half-sites, as the CTE is required for protein interaction with HMGB (not shown). Therefore, the CTE is essential for ER␣ and ER␤ interaction with an ERE half-site element.
Most characterized estrogen responsive target genes contain EREs that diverge from the consensus palindrome ERE, or contain multiple half-site HREs, suggesting that the requirement of the CTE for recognition of ERE half-sites may be physiologically relevant. In further support of a role for recognition of divergent target DNA sites, the CTE of the AR DBD was also shown to be required for AR recognition of a novel direct repeat androgen response element (46) . How the ER CTE mediates recognition of ERE half-sites is not known, but presumably occurs in a manner similar to that of class II and orphan nuclear receptors where the CTE makes additional nonspecific DNA contacts outside the HRE to stabilize the specific interactions of the core DBD.
Based on biochemical and structural studies, the CTE of class II and orphan nuclear receptors has been well documented to participate in stabilizing receptor binding to cognate target DNA sequences. In contrast, much less is known about the CTE of the steroid class of nuclear receptor. This paper extends our previous work on the PR CTE, now showing that the CTE of both ER␣ and ER␤ is required for protein interaction with the coregulatory protein HMGB and for HMBG enhancement of receptor binding to specific target ERE DNAs. However, the CTE of ER␣ appears to have a unique property that is responsible for the higher intrinsic DNA binding affinity of ER␣ than ER␤. An unexpected finding of this study was the requirement of the CTE of both ERs to interact with ERE half-sites independent of the HMGB. Taken together, the present results reveal an important role for the CTE in estrogen receptor transcriptional signaling. It will be important for future studies to determine the structure of a steroid receptor CTE and how it interacts with HMGB and/or DNA. 
